Novel coronavirus (COVID-19)
Coronaviruses are the common cause of respiratory infections in humans – it’s one of the pathogens that can cause the common cold. However, some strains are much more dangerous.
The COVID-19 novel coronavirus is a new strain of coronavirus affecting humans, and we are still learning about it.
There is currently no specific vaccine or treatment for COVID-19 infection.
The search for a global vaccine
On 22 May 2020, we announced $10 million funding from the Queensland Government Advance Queensland initiative, along with $3 million from the Australian Government and $3.5 million from The Paul Ramsay Foundation to fast-track a promising vaccine for COVID-19 being worked on by the University of Queensland’s (UQ) School of Chemistry and Molecular Biosciences.
The research team includes Professor Paul Young, Professor Trent Munro, Dr Keith Chappell and Dr David Watterson.
Nobel Laureate and world-renowned immunologist Professor Peter Doherty said this is one of the most promising vaccine approaches on the horizon globally.
UQ is one of two Australian organisations and one of only nine globally to be tasked by the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine against COVID-19.
There are around 100 companies and entities worldwide developing a COVID-19 vaccine – all with different approaches from that of UQ.